OmniAb, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() ACET
Adicet Bio, Inc. |
$1.09 | $110.93 M | -0.46 | 143 | $0 |
![]() BCAB
BioAtla, Inc. |
$0.60 | $73.14 M | -0.61 | 65 | $0 |
![]() CGEM
Cullinan Oncology, Inc. |
$11.78 | $1.29 B | -7.16 | 111 | $0 |
![]() ERAS
Erasca, Inc. |
$2.67 | $647.94 M | -2.83 | 126 | $0 |
![]() EWTX
Edgewise Therapeutics, Inc. |
$26.56 | $1.65 B | -11.47 | 110 | $0 |
![]() GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
![]() IDYA
IDEAYA Biosciences, Inc. |
$25.69 | $2.88 B | -19 | 131 | $7.00 M |
![]() IKNA
Ikena Oncology, Inc. |
$1.66 | $84.45 M | -1.11 | 14 | $0 |
![]() IPSC
Century Therapeutics, Inc. |
$1.05 | $244.54 M | -1.32 | 152 | $2.24 M |
![]() ITOS
iTeos Therapeutics, Inc. |
$8.06 | $603.25 M | -4.42 | 173 | $35.00 M |
![]() KROS
Keros Therapeutics, Inc. |
$15.64 | $1.76 B | -9.45 | 169 | $3.55 M |
![]() LEGN
Legend Biotech Corporation |
$34.72 | $8.31 B | -17.66 | 2600 | $627.24 M |
![]() NGM
NGM Biopharmaceuticals, Inc. |
$1.54 | $128.53 M | -0.89 | 138 | $4.42 M |
![]() OLMA
Olema Pharmaceuticals, Inc. |
$5.50 | $734.41 M | -6.56 | 87 | $0 |
![]() PASG
Passage Bio, Inc. |
$0.76 | $73.04 M | -0.77 | 58 | $0 |
![]() PMVP
PMV Pharmaceuticals, Inc. |
$1.57 | $85.40 M | -1.26 | 47 | $0 |
![]() TALS
Talaris Therapeutics, Inc. |
$2.72 | $116.44 M | -1.56 | 84 | $0 |
![]() VOR
Vor Biopharma Inc. |
$1.74 | $83.62 M | -0.69 | 168 | $0 |
![]() VRNA
Verona Pharma plc |
$44.81 | $983.52 M | -15.16 | 209 | $42.28 M |